Rocket


News + Filings
Transactions





Berger Mark Stanley

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
02/18/2023Genprex, Inc.GNPXGrantCommon Stock245k$0.00$0 02/18/2023
02/04/2022Genprex, Inc.GNPXGrantStock Option (right to buy)98.8k$2.20$217.2k 02/04/2022
09/27/2021Genprex, Inc.GNPXGrant 550k$2.85$1.6M 09/27/2021
09/01/2021Actinium Pharmaceuticals, Inc.ATNMGrantStock Option (Right to Buy)67.2k$0.00$0 09/01/2021
08/12/2020Actinium Pharmaceuticals, Inc.ATNMGrantStock Option (Right to Buy)46.7k$0.00$0 08/12/2020
07/12/2019Actinium Pharmaceuticals, Inc.ATNMGrantOptions to purchase common stock400k$0.23$92.8k 07/12/2019
03/05/2019Actinium Pharmaceuticals, Inc.ATNMExercise (in-the-money or at-the-money)Common Stock3.5k$0.60$2.1k 03/05/2019
07/13/2018Actinium Pharmaceuticals, Inc.ATNMGrantOptions to purchase common stock250k$0.78$195.7k 07/13/2018
03/06/2018Actinium Pharmaceuticals, Inc.ATNMOther (acquisition)Series B Warrants10.5k$0.70$7.4k 03/06/2018
03/06/2018Actinium Pharmaceuticals, Inc.ATNMOther (acquisition)Series A Warrants3.5k$0.60$2.1k 03/06/2018
03/06/2018Actinium Pharmaceuticals, Inc.ATNMOther (acquisition)Common Stock14k$0.50$7k 03/06/2018

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy